van de Giessen, Elsmarieke3; Hesse, Swen3; Caan, Matthan W A3; Zientek, Franziska3; Dickson, John C3; Tossici-Bolt, Livia3; Sera, Terez3; Asenbaum, Susanne3; Guignard, Renaud3; Akdemir, Umit O3; Knudsen, Karen Birgitte Moos4; Nobili, Flavio3; Pagani, Marco3; Vander Borght, Thierry3; Van Laere, Koen3; Varrone, Andrea3; Tatsch, Klaus3; Booij, Jan3; Sabri, Osama3
1 Section of Neurology, Psychiatry and Sensory Sciences, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet2 Department of Clinical Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet3 unknown4 Department of Clinical Medicine, Department of Clinical Medicine, Faculty of Health and Medical Sciences, Københavns Universitet
A multi-center European study in healthy volunteers
Dopamine is one among several neurotransmitters that regulate food intake and overeating. Thus, it has been linked to the pathophysiology of obesity and high body mass index (BMI). Striatal dopamine D(2) receptor availability is lower in obesity and there are indications that striatal dopamine transporter (DAT) availability is also decreased. In this study, we tested whether BMI and striatal DAT availability are associated.
Neuroimage, 2013, Vol 64, p. 61-7
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't